< Back to companies

Facense develops lightweight smartglasses with tiny sensors that continuously and unobtrusively measure vital signs. The company plans to add software updates to detect and predict various medical conditions including hypertension, stroke, congestive heart failure, asthma, chronic obstructive pulmonary disease, and migraines. Facense's patent portfolio includes more than 30 US patents and dozens of patent applications around the world on smartglasses with sensors for wellness, telehealth, safety, and industrial applications.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.facense.com

Categories

Cardiovascular DiseaseNeurologyPulmonary/ Asthma

Disease Areas

Technologies

Smart WearablesSensorsWearable DevicesPredictive Analytics
Only accessible to MedStartr community members. Join now

What do you think of Facense (פסנס)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now